| Literature DB >> 33649311 |
Yantao Ma1,2,3,4, Handan Xie1,3, Xiaomin Du1,3,4,5, Lipeng Wang1,3, Xueqin Jin6,7, Qianqian Zhang8,9, Yawen Han1,2,3,4, Shicheng Sun1,10, Longteng Wang11, Xiang Li3, Changjiang Zhang8,9, Mengdi Wang8, Cheng Li12, Jun Xu1,3, Zhuo Huang13, Xiaoqun Wang14,15,16,17, Zhen Chai18, Hongkui Deng19,20,21.
Abstract
In mammals, many organs lack robust regenerative abilities. Lost cells in impaired tissue could potentially be compensated by converting nearby cells in situ through in vivo reprogramming. Small molecule-induced cell reprogramming offers a temporally flexible and non-integrative strategy for altering cell fate, which is, in principle, favorable for in vivo reprogramming in organs with notoriously poor regenerative abilities, such as the brain. Here, we demonstrate that in the adult mouse brain, small molecules can reprogram astrocytes into neurons. The in situ chemically induced neurons resemble endogenous neurons in terms of neuron-specific marker expression, electrophysiological properties, and synaptic connectivity. Our study demonstrates the feasibility of in vivo chemical reprogramming in the adult mouse brain and provides a potential approach for developing neuronal replacement therapies.Entities:
Year: 2021 PMID: 33649311 DOI: 10.1038/s41421-021-00243-8
Source DB: PubMed Journal: Cell Discov ISSN: 2056-5968 Impact factor: 10.849